Search research articles
Contact Us
Filters
Showing results (71-80 of 105) with videos related to
Page
of 11
Sort By:
British Journal of Clinical Pharmacology
|
March 24, 2026
Systematic review and scoring-based selection of pharmacokinetic models for precision dosing of vancomycin in neonates and children
Zoë Vander Elst, Pieter-Jan Spiessens, Dorian Vanneste, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
June 16, 2022
Multi-model averaging improves the performance of model-guided infliximab dosing in patients with inflammatory bowel diseases
Wannee Kantasiripitak, An Outtier, Sebastian G Wicha, et al.
Journal of Crohn'S & Colitis
|
January 8, 2016
Variability in Golimumab Exposure: A 'Real-Life' Observational Study in Active Ulcerative Colitis
Iris Detrez, Erwin Dreesen, Thomas Van Stappen, et al.
Clinics and Research in Hepatology and Gastroenterology
|
May 16, 2024
Forecasted infliximab concentrations during induction predict time to remission and sustained disease control of inflammatory bowel disease
Severine Vermeire, Marla C Dubinsky, Shervin Rabizadeh, et al.
Inflammatory Bowel Diseases
|
November 17, 2021
Corrigendum to: Pharmacokinetic-Pharmacodynamic Model of Vedolizumab for Targeting Endoscopic Remission in Patients with Crohn Disease: Posthoc Analysis of the LOVE-CD Study
Jurij Hanzel, Erwin Dreesen, Séverine Vermeire, et al.
Inflammatory Bowel Diseases
|
June 17, 2021
Pharmacokinetic-Pharmacodynamic Model of Vedolizumab for Targeting Endoscopic Remission in Patients With Crohn Disease: Posthoc Analysis of the LOVE-CD Study
Jurij Hanzel, Erwin Dreesen, Séverine Vermeire, et al.
Cellular Oncology (Dordrecht, Netherlands)
|
June 18, 2024
The PPP2R1A cancer hotspot mutant p.R183W increases clofarabine resistance in uterine serous carcinoma cells by a gain-of-function mechanism
Michiel Remmerie, Rüveyda Dok, Zhigang Wang, et al.
Journal of Thrombosis and Haemostasis : JTH
|
July 5, 2025
Population pharmacokinetics of edoxaban in geriatric patients with atrial fibrillation
Angela Elma Edwina, Lorenz Van der Linden, Louise Debruyne, et al.
Journal of Crohn'S & Colitis
|
September 11, 2019
Influence of Drug Exposure on Vedolizumab-Induced Endoscopic Remission in Anti-Tumour Necrosis Factor [TNF] Naïve and Anti-TNF Exposed IBD Patients
Bram Verstockt, Evelien Mertens, Erwin Dreesen, et al.
Medical Mycology
|
September 20, 2022
Liposomal amphotericin B exposure in critically ill patients: a prospective pharmacokinetic study
Ruth Van Daele, Joost Wauters, Omar Elkayal, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 105) with videos related to
Sort By:
Page
of 11
British Journal of Clinical Pharmacology
|
March 24, 2026
Systematic review and scoring-based selection of pharmacokinetic models for precision dosing of vancomycin in neonates and children
Zoë Vander Elst, Pieter-Jan Spiessens, Dorian Vanneste, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
June 16, 2022
Multi-model averaging improves the performance of model-guided infliximab dosing in patients with inflammatory bowel diseases
Wannee Kantasiripitak, An Outtier, Sebastian G Wicha, et al.
Journal of Crohn'S & Colitis
|
January 8, 2016
Variability in Golimumab Exposure: A 'Real-Life' Observational Study in Active Ulcerative Colitis
Iris Detrez, Erwin Dreesen, Thomas Van Stappen, et al.
Clinics and Research in Hepatology and Gastroenterology
|
May 16, 2024
Forecasted infliximab concentrations during induction predict time to remission and sustained disease control of inflammatory bowel disease
Severine Vermeire, Marla C Dubinsky, Shervin Rabizadeh, et al.
Inflammatory Bowel Diseases
|
November 17, 2021
Corrigendum to: Pharmacokinetic-Pharmacodynamic Model of Vedolizumab for Targeting Endoscopic Remission in Patients with Crohn Disease: Posthoc Analysis of the LOVE-CD Study
Jurij Hanzel, Erwin Dreesen, Séverine Vermeire, et al.
Inflammatory Bowel Diseases
|
June 17, 2021
Pharmacokinetic-Pharmacodynamic Model of Vedolizumab for Targeting Endoscopic Remission in Patients With Crohn Disease: Posthoc Analysis of the LOVE-CD Study
Jurij Hanzel, Erwin Dreesen, Séverine Vermeire, et al.
Cellular Oncology (Dordrecht, Netherlands)
|
June 18, 2024
The PPP2R1A cancer hotspot mutant p.R183W increases clofarabine resistance in uterine serous carcinoma cells by a gain-of-function mechanism
Michiel Remmerie, Rüveyda Dok, Zhigang Wang, et al.
Journal of Thrombosis and Haemostasis : JTH
|
July 5, 2025
Population pharmacokinetics of edoxaban in geriatric patients with atrial fibrillation
Angela Elma Edwina, Lorenz Van der Linden, Louise Debruyne, et al.
Journal of Crohn'S & Colitis
|
September 11, 2019
Influence of Drug Exposure on Vedolizumab-Induced Endoscopic Remission in Anti-Tumour Necrosis Factor [TNF] Naïve and Anti-TNF Exposed IBD Patients
Bram Verstockt, Evelien Mertens, Erwin Dreesen, et al.
Medical Mycology
|
September 20, 2022
Liposomal amphotericin B exposure in critically ill patients: a prospective pharmacokinetic study
Ruth Van Daele, Joost Wauters, Omar Elkayal, et al.
Page
of 11